Apellis Pharmaceuticals, Inc. (APLS)

CIK 1492422 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Apellis Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jun 5, 2026SCHEDULE 13G/A0000895421-26-000190
May 26, 202615-12G0000950157-26-000636
May 15, 2026SCHEDULE 13G/A0001172661-26-002024
May 15, 2026SCHEDULE 13G/A0001493215-26-000090
May 14, 202640001193125-26-224611
May 14, 202625-NSE0001354457-26-000449
May 14, 202640001193125-26-224606
May 14, 202640001193125-26-224592
May 14, 202640001193125-26-224597
May 14, 2026S-8 POS0001193125-26-222945
May 14, 2026S-8 POS0001193125-26-222940
May 14, 202640001193125-26-224624
May 14, 20268-K0001193125-26-222923
May 14, 2026SC TO-T/A0001193125-26-222837
May 14, 202640001193125-26-224585
May 14, 202640001193125-26-224609
May 14, 2026SC 14D9/A0001193125-26-222828
May 14, 2026SCHEDULE 13D/A0000950157-26-000611
May 14, 2026S-8 POS0001193125-26-222953
May 14, 2026S-8 POS0001193125-26-222955
May 14, 2026S-8 POS0001193125-26-222948
May 14, 2026S-8 POS0001193125-26-222944
May 14, 2026S-8 POS0001193125-26-222939
May 14, 2026S-8 POS0001193125-26-222947
May 14, 2026S-8 POS0001193125-26-222949